Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. (Q37189243)
Jump to navigation
Jump to search
scientific article published on 28 April 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial. |
scientific article published on 28 April 2016 |
Statements
Progression-Free Survival Among Patients With Well-Differentiated or Dedifferentiated Liposarcoma Treated With CDK4 Inhibitor Palbociclib: A Phase 2 Clinical Trial (English)
Sandra P D'Angelo
Mrinal M Gounder
Cristina R Antonescu
Mark A Dickson
Gary K Schwartz
Mary Louise Keohan
Ping Chi
Jonathan Landa
Li-Xuan Qin
Aimee M Crago
Samuel Singer
1 reference